ACTV Biotechnology is a pharmaceutical company that developed ingredients for anti-aging, spot-removing, and anti-cancer.
ACTV Biotechnology has raised $1.2M in total funding. The most recent round was Equity Crowdfunding. The last funding was announced in May 2023.
ACTV Biotechnology's investors include Fonbulucu, Hakan Yıldız, SUSU Yatırım, Hade Biotechnology, FonTR GSYF.
ACTV Biotechnology is headquartered in Büyükçekmece, Turkey.
ACTV Biotechnology is a pharmaceutical company that developed ingredients for anti-aging, spot-removing, and anti-cancer.
ACTV Biotechnology is at the Equity Crowdfunding stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ACTV Biotechnology — Funding & Investors." VCBacked, May 24, 2023, https://www.vcbacked.co/company/actv-biotechnology. Accessed October 4, 2026.
VCBacked. (2023). ACTV Biotechnology — Funding & Investors. Retrieved October 4, 2026, from https://www.vcbacked.co/company/actv-biotechnology
{{cite web |title=ACTV Biotechnology — Funding & Investors |url=https://www.vcbacked.co/company/actv-biotechnology |website=VCBacked |access-date=October 4, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated